sub:provenance { beldoc:dce:description "Approximately 61,000 statements." ; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ; dce:title "BEL Framework Large Corpus Document" ; pav:authoredBysub:_4 ; pav:version "20131211" . sub:_3prov:value "Differentiation of human THP-1 cells into foam cells on treatment with 12-O-tetradecanoylphorbol 13-acetate (PMA) was observed in atherosclerotic lesions. When these THP-1 differentiated cells were subsequently treated with oxidized low density lipoprotein (Ox-LDL), it was observed that CD64 (FCFGR1) expressed low. At the end of fourth day of treatment with Ox-LDL the expression of CD64 was decreased by 4.27-folds when compared with control. This indicates that Ox-LDL down-regulates CD64 in differentiated THP-1cells." ; prov:wasQuotedFrompubmed:10973959 . sub:_4rdfs:label "Selventa" . sub:assertionprov:hadPrimarySourcepubmed:10973959 ; prov:wasDerivedFrombeldoc: , sub:_3 . }